Generic placeholder image

Current Protein & Peptide Science

Author(s): Shweta Katiyar*, Dhananjay Yadav* and Sanjeev K. Singh

DOI: 10.2174/0113892037269116231115065458

DownloadDownload PDF Flyer Cite As
Markers of Oxidative Stress and Tyrosinase Activity in Melasma Patients: A Biochemical Investigation

Page: [183 - 188] Pages: 6

  • * (Excluding Mailing and Handling)

Abstract

Background: Melasma is a skin hyperpigmentary disorder that develops over time. Genetic factors, oxidative stress, female sex hormones, and UV light may all play a role in the disorder's progression.

Aims: To compare the levels of oxidative stress and tyrosinase activity in melasma patients with healthy volunteers.

Methods: After written consent, 130 patients were enrolled in a case–control study. 65 cases were of melasma disorder, and 65 were served as control. Homogenized skin tissues were taken and used to estimate superoxide dismutase (SOD), catalase (CAT), reduced glutathione (GSH), glutathione peroxidase (GPx) (antioxidants), malondialdehyde (MDA) and tyrosine hydroxylase (TH).

Results: Melasma patients had lower basal levels of systemic antioxidants than healthy subjects. Tyrosinase activity was shown to be greater in lesional skin than in non-lesional skin. In controls, there was a good positive relationship between TH and MDA and an excellent negative relationship between GPx and GSH. In melasma patients, there were significant associations between CAT, GPx, SOD and MDA.

Conclusions: Increased oxidative stress may affect tyrosinase activity and eumelanin synthesis via the anabolic pathway of melanin synthesis, according to our findings. In conclusion, we discovered a negative relationship between antioxidants and tyrosinase activity.

[1]
Ogbechie-Godec, O.A.; Elbuluk, N. Melasma: An up-to-date comprehensive review. Dermatol. Ther. (Heidelb.), 2017, 7(3), 305-318.
[http://dx.doi.org/10.1007/s13555-017-0194-1] [PMID: 28726212]
[2]
Basit, H.; Godse, K.V.; Al Aboud, A.M. Melasma; StatPearls Publications: Treasure Island (FL), 2022.
[3]
Tomar, A.; Purohit, S.; Gaur, K.; Kaur, M.; Kashyap, A. A case series of 500 melasma cases: A descriptive study. Int Multi J Health, 2017, 3(2), 34-39.
[4]
Sarkar, R.; Gokhale, N.; Godse, K.; Ailawadi, P.; Arya, L.; Sarma, N.; Torsekar, R.G.; Somani, V.K.; Arora, P.; Majid, I.; Ravichandran, G.; Singh, M.; Aurangabadkar, S.; Arsiwala, S.; Sonthalia, S.; Salim, T.; Shah, S. Medical management of melasma: A review with consensus recommendations by Indian pigmentary expert group. Indian J. Dermatol., 2017, 62(6), 450.
[http://dx.doi.org/10.4103/ijd.IJD_489_17] [PMID: 29263529]
[5]
Sarkar, R.; Ailawadi, P.; Garg, S. Melasma in men a review of clinical, etiological, and management issues. J. Clin. Aesthet. Dermatol., 2018, 11(2), 53-59.
[PMID: 29552277]
[6]
Sarkar, R.; Ghunawat, S.; Narang, I.; Verma, S.; Garg, V.K.; Dua, R. Role of broad-spectrum sunscreen alone in the improvement of melasma area severity index (MASI) and Melasma Quality of Life Index in melasma. J. Cosmet. Dermatol., 2019, 18(4), 1066-1073.
[http://dx.doi.org/10.1111/jocd.12911] [PMID: 31033184]
[7]
Nayak, C.S.; Nouveau, S.; Agrawal, D.; Kohli, M.; Bernerd, F.; Misra, N. Skin hyperpigmentation in Indian population: Insights and best practice. Indian J. Dermatol., 2016, 61(5), 487-495.
[http://dx.doi.org/10.4103/0019-5154.190103] [PMID: 27688436]
[8]
Krupa, S.D.S. Melasma/chloasma/mark of pregnancy. Aestheticians J, 2012, 2(1), 7-11.
[9]
Pichardo, R.; Vallejos, Q. The prevalence of melasma and its association with quality of life among adult male migrant latino workers. Int. J. Dermatol., 2009, 48(1), 22-26.
[http://dx.doi.org/10.1111/j.1365-4632.2009.03778.x] [PMID: 19126046]
[10]
Passeron, T.; Picardo, M. Melasma, a photoaging disorder. Pigment Cell Melanoma Res., 2018, 31(4), 461-465.
[http://dx.doi.org/10.1111/pcmr.12684] [PMID: 29285880]
[11]
Jiang, J.; Akinseye, O.; Tovar-Garza, A.; Pandya, A.G. The effect of melasma on self-esteem: A pilot study. Int. J. Womens Dermatol., 2018, 4(1), 38-42.
[http://dx.doi.org/10.1016/j.ijwd.2017.11.003] [PMID: 29872675]
[12]
Aishwarya, K.; Bhagwat, P.V.; John, N. Current concepts in melasma- a review article. J Skin Sexually Trans Dis, 2019, 2(1), 13-17.
[13]
Hollinger, J.C.; Angra, K.; Halder, R.M. Are natural ingredients effective in the management of hyperpigmentation? A systematic review. J. Clin. Aesthet. Dermatol., 2018, 11(2), 28-37.
[PMID: 29552273]
[14]
Espósito, A.C.C.; Brianezi, G.; de Souza, N.P.; Miot, L.D.B.; Marques, M.E.A.; Miot, H.A. Exploring pathways for sustained melanogenesis in facial melasma: An immunofluorescence study. Int. J. Cosmet. Sci., 2018, 40(4), 420-424.
[http://dx.doi.org/10.1111/ics.12468] [PMID: 29846953]
[15]
Sonthalia, S.; Sarkar, R. Etiopathogenesis of melasma. Pigment International, 2015, 2(1), 21-27.
[http://dx.doi.org/10.4103/2349-5847.159389]
[16]
Gutteridge, J.M.C.; Halliwell, B. Mini-Review: Oxidative stress, redox stress or redox success? Biochem. Biophys. Res. Commun., 2018, 502(2), 183-186.
[http://dx.doi.org/10.1016/j.bbrc.2018.05.045] [PMID: 29752940]
[17]
Zainuddin, F.; Anwar, A.I. The Correlation between malondialdehyde serum levels and the duration of sun exposure; and melasma area and severity index in patients with melasma in makassar. Am. J. Clin. Exp. Med., 2016, 4(3), 68-75.
[http://dx.doi.org/10.11648/j.ajcem.20160403.16]
[18]
Choubey, V.; Sarkar, R.; Garg, V.; Kaushik, S.; Ghunawat, S.; Sonthalia, S. Role of oxidative stress in melasma: A prospective study on serum and blood markers of oxidative stress in melasma patients. Int. J. Dermatol., 2017, 56(9), 939-943.
[http://dx.doi.org/10.1111/ijd.13695] [PMID: 28681382]
[19]
Winterbourn, C.C.; Hawkins, R.E.; Brian, M.; Carrell, R.W. The estimation of red cell superoxide dismutase activity. J. Lab. Clin. Med., 1975, 85(2), 337-341.
[PMID: 803541]
[20]
Abei, H. Catalase in vitro. Methods Enzymol., 1984, 105, 121-6.
[21]
Brehe, J.E.; Burch, H.B. Enzymatic assay for glutathione. Anal. Biochem., 1976, 74(1), 189-197.
[http://dx.doi.org/10.1016/0003-2697(76)90323-7] [PMID: 962073]
[22]
Paglia, D.E.; Valentine, W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med., 1967, 70(1), 158-169.
[PMID: 6066618]
[23]
Jean, C.D.; Maryse, T.; Marie, J.F. Plasma malondialdehyde levels during myocardial infarction. Clin. Chim. Acta, 1983, 129, 31922.
[24]
Kim, M.; Shibata, T.; Kwon, S.; Park, T.J.; Kang, H.Y. Ultraviolet-irradiated endothelial cells secrete stem cell factor and induce epidermal pigmentation. Sci. Rep., 2018, 8(1), 4235.
[http://dx.doi.org/10.1038/s41598-018-22608-y] [PMID: 29523807]
[25]
Katiyar, S.; Yadav, D. Correlation of oxidative stress with melasma: An overview. Curr. Pharm. Des., 2022, 28(3), 225-231.
[http://dx.doi.org/10.2174/1381612827666211104154928] [PMID: 34736377]
[26]
Sarkar, R.; Bansal, S. Skin pigmentation in relation to gender: Truth and myth. Pigment International, 2017, 4(1), 1-2.
[http://dx.doi.org/10.4103/2349-5847.208350]
[27]
Im, S.; Lee, E.S.; Kim, W.; On, W.; Kim, J.; Lee, M.; Kang, W.H. Donor specific response of estrogen and progesterone on cultured human melanocytes. J. Korean Med. Sci., 2002, 17(1), 58-64.
[http://dx.doi.org/10.3346/jkms.2002.17.1.58] [PMID: 11850590]
[28]
Kumre, K.; Varma, K.; Sharma, H.; Singh, U. Study of hormonal profile in female melasma patients in a tertiary care hospital. J. Evol. Med. Dent. Sci., 2016, 5(31), 1663-1666.
[http://dx.doi.org/10.14260/jemds/2016/392]
[29]
Ertam, I.; Ozkapu, T. Antioxidant activity in melasma. Turkderm-Turk Arch Dermatol Venereol, 2018, 52, 33-36.
[30]
Zamani, M. Melasma: A brief overview of classification and treatment modalities. In: Aesthetics J; , 2016; 2016, .
[31]
Hamadi, S.A.; Mohammed, M.M.; Aljaf, A.N.; Ali Abdulrazak, A. The role of topical and oral melatonin in management of melasma patients. J Arab Uni Basic Applied Sci, 2009, 8, 30-32.
[32]
Seçkin, H.Y.; Kalkan, G.; Baş, Y.; Akbaş, A.; Önder, Y.; Özyurt, H.; Şahin, M. Oxidative stress status in patients with melasma. Cutan. Ocul. Toxicol., 2014, 33(3), 212-217.
[http://dx.doi.org/10.3109/15569527.2013.834496] [PMID: 24147944]
[33]
Kowalczyk, P.; Sulejczak, D.; Kleczkowska, P.; Bukowska-Ośko, I.; Kucia, M.; Popiel, M.; Wietrak, E.; Kramkowski, K.; Wrzosek, K.; Kaczyńska, K. Mitochondrial oxidative stress- a causative factor and therapeutic target in many diseases. Int. J. Mol. Sci., 2021, 22(24), 13384.
[http://dx.doi.org/10.3390/ijms222413384] [PMID: 34948180]
[34]
Xing, X.; Dan, Y.; Xu, Z.; Xiang, L. Implications of oxidative stress in the pathogenesis and treatment of hyperpigmentation disorders. Oxid. Med. Cell. Longev., 2022, 2022, 1-12.
[http://dx.doi.org/10.1155/2022/7881717] [PMID: 35087618]
[35]
Conrad, M.; Kagan, V.E.; Bayir, H.; Pagnussat, G.C.; Head, B.; Traber, M.G.; Stockwell, B.R. Regulation of lipid peroxidation and ferroptosis in diverse species. Genes Dev., 2018, 32(9-10), 602-619.
[http://dx.doi.org/10.1101/gad.314674.118] [PMID: 29802123]
[36]
Salmon, T.B.; Evert, B.A.; Song, B.; Doetsch, P.W. Biological consequences of oxidative stress-induced DNA damage in Saccharomyces cerevisiae. Nucleic Acids Res., 2004, 32(12), 3712-3723.
[http://dx.doi.org/10.1093/nar/gkh696] [PMID: 15254273]
[37]
Babbush, K.; Babbush, R.; Khachemoune, A. The therapeutic use of antioxidants of melasma. J. Drugs Dermatol., 2020, 19(8), 788-792.
[http://dx.doi.org/10.36849/JDD.2020.5079] [PMID: 32845595]
[38]
D’Mello, S.; Finlay, G.; Baguley, B.; Askarian-Amiri, M. Signaling pathways in melanogenesis. Int. J. Mol. Sci., 2016, 17(7), 1144.
[http://dx.doi.org/10.3390/ijms17071144] [PMID: 27428965]
[39]
Kang, H.Y.; Suzuki, I.; Lee, D.J.; Ha, J.; Reiniche, P.; Aubert, J.; Deret, S.; Zugaj, D.; Voegel, J.J.; Ortonne, J.P. Transcriptional profiling shows altered expression of wnt pathway- and lipid metabolism-related genes as well as melanogenesis-related genes in melasma. J. Invest. Dermatol., 2011, 131(8), 1692-1700.
[http://dx.doi.org/10.1038/jid.2011.109] [PMID: 21562572]